The microbiologist has turned her attention full-time to unearthing problematic figures in papers—for free.

An investigation finds 20 papers by Santosh Katiyar, who studied alternative treatments for cancer, include image manipulation.

Scientists who accept funding with the tacit agreement that they keep their mouths shut about the government are far more threatening to an independent academy than those who speak their minds.

A look at this year’s most memorable retractions

A look at this year’s most memorable retractions

Grading journals on how well they share information with readers will help deliver accountability to an industry that often lacks it.

Max Rothschild (left) in Uganda. Credit: courtesy of Max Rothschild" />Max Rothschild (left) in Uganda. Credit: courtesy of Max Rothschild The Rothschild lineage is often associated with Jewish tradition, banking, and fantastic wines. But Max Rothschild, a researcher at Iowa State University, is associated with some decidedly nonkosher animals: pigs. And, more recently, shrimp. When he was about 7 or 8 years old, Rothschild had a different kind

In a story that probably hit close to home to anyone who ever clicked on the wrong email recipient in Outlook, it turns out that attorneys for Lilly sent confidential documents to a New York Times reporter named Alex Berenson instead of an attorney named Bradford Berenson. Katherine Eban, who has linkurl:written for us;http://www.the-scientist.com/article/home/52963/ about biosecurity, linkurl:reported the story;http://www.portfolio.com/news-markets/top-5/2008/02/05/Eli-Lilly-E-Mail-to-New-York

What is the linkurl:responsibility of a company sponsoring a clinical trial;http://blogs.wsj.com/health/2008/01/31/when-drug-trials-go-wrong/ when one of its participants gets sick? That's the theme of a linkurl:story;http://online.wsj.com/article/SB120173515260330205.html in today's Wall Street Journal. As Sarah Rubenstein reports, the family of a woman who took part in a clinical trial of a drug for Parkinson's disease is suing the sponsors and university organizers of the trial. They say the

Do science bloggers need a code of ethics? Should they disclose conflicts of interest? Moderate comments? Protect anonymous colleagues? Those were some of the questions raised at the first session, led by linkurl:Janet Stemwedel, ;http://scienceblogs.com/ethicsandscience/ that I went to today at the linkurl:North Carolina Science Blogging Conference. ;http://wiki.scienceblogging.com/scienceblogging/ It's the second such conference, and I was stimulated enough by last year's to come back. (I ev

When we asked readers who their linkurl:favorite science bloggers;http://www.the-scientist.com/news/home/53596/ were last year, we started the discussion by reaching out to a number of leading science bloggers. The bloggers who responded were all men, and most of the blogs they recommended were written by men. So perhaps understandably, GrrlScientist and others linkurl:wondered why we hadn't asked any women science bloggers about their favorites. ;http://scienceblogs.com/grrlscientist/2007/09/fa

For those of you cheering the linkurl:pygmy rabbit, ;http://www.the-scientist.com/article/display/53232/ you can let up a restrained cheer today - a small one, perhaps, in keeping with the size of the animals. The US Fish and Wildlife Service (USFWS), bowing to a linkurl:September court order, ;http://www.the-scientist.com/blog/display/53716/ is reconsidering whether more members of the tiny species should be covered under the Endangered Species Act. The agency had previously denied coverage of

A Waiting Trial In the summer of 2006, Doug Bergman had a needle plunged into his heart 10 times for science. Now he has leukemia. By Ivan Oransky Photographs by John Borge Related Articles: Trial of the Heart Scientist to Watch: Amy Wagers - Setting the record straight Slideshow: A Waiting Trial When I knock on the door of room 733 of the MeritCare Roger Maris Cancer Center in Fargo, ND, Doug Bergman is sitting up in his bed. He's been expecting me, but it's n

var FO = { movie:"http://www.the-scientist.com/supplementary/flash/54072/54072.swf", width:"520", height:"580", majorversion:"8", build:"0", xi:"true"}; UFO.create(FO, "ufoDemo"); Slideshow: A Waiting Trial In October, Deputy Editor Ivan Oransky traveled to Fargo, North Dakota, to interview Doug Bergman in the hospital. Bergman had developed leukemia a little more than a year after taking part in a clinical trial of stem cells to repair his heart. (For a st

A leading child psychiatrist got thousands of emails this week criticizing a provocative advertising campaign by his center to raise awareness of mental illness in children. The New York Times linkurl:reported;http://www.nytimes.com/2007/12/20/business/media/20child.html that Harold Koplewicz, the director of New York University's Child Study Center, received more than 3,000 emails in response to the ads, which used fake ransom notes to call attention to autism and depression in children. For e